Oftan Dexa (Dexamethasone Sodium Phosphate)

Oftan Dexa is a corticosteroid that acts on inflammatory and immune pathways to provide rapid symptom control in several clinical settings.

• Allergic reactions: helps reduce the severity of moderate to severe allergic responses.
• Asthma exacerbations: improves airway inflammation and facilitates breathing recovery.
• Cerebral edema: decreases brain swelling associated with tumors or trauma.
• Post‑operative inflammation: limits surgical tissue inflammation and pain.
• Autoimmune disorders: suppresses immune‑mediated inflammation in conditions such as lupus and rheumatoid arthritis.

• Dexamethasone sodium phosphate is a synthetic glucocorticoid that readily enters cells and binds to cytosolic glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it modulates gene transcription, suppressing pro‑inflammatory cytokines and up‑regulating anti‑inflammatory proteins, thereby reducing inflammation and immune activation.

Side effects vary with dose, duration and route of administration, but most are related to systemic glucocorticoid activity.

Common Side Effects

• Elevated blood glucose levels
• Mood changes, including irritability or euphoria
• Increased appetite and weight gain
• Fluid retention causing mild edema
• Insomnia or difficulty sleeping
• Gastro‑intestinal discomfort

Serious or Rare Side Effects

• Severe infection risk due to immune suppression
• Osteoporosis or pathological fractures
• Adrenal insufficiency on abrupt discontinuation
• Hyper‑cortisolism (Cushing‑like syndrome)
• Vision changes such as cataracts or glaucoma
• Severe allergic reactions (anaphylaxis)

When using Oftan Dexa, clinicians should assess patient history and monitor for systemic effects typical of corticosteroids.

• Screen for diabetes: monitor blood glucose regularly.
• Evaluate infection risk: avoid use in uncontrolled infections.
• Assess bone health: consider calcium/vitamin D supplementation.
• Monitor psychiatric status: watch for mood swings or psychosis.
• Use the lowest effective dose: limit duration to reduce adverse outcomes.
• Store at ambient temperature: keep in original container, protect from light and moisture.

Oftan Dexa may alter the activity of several co‑administered medicines, requiring dose adjustments or heightened monitoring.

Major Interactions (Avoid)

• Live vaccines: may diminish vaccine efficacy and increase infection risk.
• Strong CYP3A4 inducers: reduce dexamethasone exposure (e.g., rifampicin).
• Anticoagulants (warfarin): enhanced anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): additive gastrointestinal irritation.
• Antidiabetic drugs: may require higher insulin or oral hypoglycemic doses.
• Antihypertensive agents: possible reduction in blood‑pressure control.